Tracker Certolizumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Regulatory News: THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and Theranostics, today announces the launch of two additional kits in

Schleswig holsteinUnited statesFrance generalPierre laurent quentinFinancial communications investor relationsHealth productsRegulatory newsTracker certolizumabTracker anti certolizumabFrench national agencyMonday julyMonday septemberEuronext growth parisManaging directorCommunications investor relationsLaurent quentin mass